An insertion variant of MGMT disrupts a STAT1 binding site and confers susceptibility to glioma
Abstract Background O 6-methylguanine-DNA methyltransferase (MGMT) is a pivotal enzyme for repairing DNA alkylation damage. Epigenetic modification of MGMT has been well known as a promising prognostic biomarker for glioma. However, the significance of genetic variations of MGMT in glioma carcinogen...
Main Authors: | Liming Huang, Wenshen Xu, Danfang Yan, Xi Shi, Xin You, Jiaqi Xu, Pingping You, Yuanyuan Ke, Lian Dai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-021-02211-4 |
Similar Items
-
An intronic genetic variation of MGMT affects enhancer activity and is associated with glioma susceptibility
by: Huang L, et al.
Published: (2018-09-01) -
Prognostic significance of MGMT promoter methylation in diffuse glioma patients
by: Nikola Jovanović, et al.
Published: (2019-01-01) -
The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis
by: Huy Gia Vuong, et al.
Published: (2020-09-01) -
Isocitrate dehydrogenase 1 and 2 genes mutations and MGMT methylation in gliomas
by: D. V. Tabakov, et al.
Published: (2017-04-01) -
Application of MGMT Promoter Methylation of Cerebrospinal Fluid in Diagnosis of Glioma
by: WANG Long, et al.
Published: (2018-10-01)